Quantcast

Latest Kidney transplantation Stories

2014-07-28 12:27:34

TOTOWA, N.J., July 28, 2014 /PRNewswire/ -- BiologicTx(®) announced their Discovery 2 Life((TM)) (D2L((TM))), a leading digital health platform designed to guide and support hospitals, clinicians and patients throughout the organ transplant continuum. D2L supports aspects of the organ transplant process, including organization of data associated with enrolling a transplant candidate into a desensitization therapeutic program, donor data management (including identifying optimal...

2014-07-23 16:27:28

LONDON, July 23, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Renal Dialysis Equipment: Technologies and Global Marketshttps://www.reportbuyer.com/product/2070056/Renal-Dialysis-Equipment-Technologies-and-Global-Markets.htmlREPORT HIGHLIGHTSThe global market for dialysis equipment and accessories was valued at $12.5 billion in 2012 and $13.4 billion in 2013. This market is expected to be valued at nearly $18.8 billion in 2018, rising at a five-year...

2014-07-22 12:30:00

3-Way Kidney Transplant Donor/Recipient Pairs Identified Using BiologicTx's Matchgrid Software TOTOWA, N.J., July 22, 2014 /PRNewswire/ -- BiologicTx(®) today announced their participation in Florida's first 3-way Kidney Paired Donation transplant exchange utilizing BiologicTx's proprietary matching software, Matchgrid(TM). The landmark surgical procedures happened on July 9 at the Miami Transplant Institute, located at Jackson Memorial Hospital in Miami, Fla....

2014-07-18 12:00:52

American Society of Nephrology Living kidney donation rates dropping among low income populations in the US The decline in living kidney donation over the past several years has been concerning and is poorly understood. A study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN) identifies low income as an important barrier to living donation, and more importantly, implies that this barrier is becoming more difficult to overcome over time. The...

2014-07-17 12:29:58

TOTOWA, N.J., July 17, 2014 /PRNewswire/ -- BiologicTx(®) was selected as the specialty pharmacy for the observational treatment registry study to evaluate the long-term treatment effects of immune globulin intravenous (IGIV) maintenance therapy on donor specific antibodies (DSA) in renal transplant recipients. Study sponsors are Databean of Mount Vernon, NY and eMax Health of White Plains, NY. http://photos.prnewswire.com/prnvar/20130520/LA16505LOGO The clinical trial involves ten...

2014-07-16 12:27:25

NxStage Patient Advocates to travel the East Coast to share the benefits of home hemodialysis LAWRENCE, Mass., July 16, 2014 /PRNewswire/ -- NxStage® Medical, Inc. (NASDAQ: NXTM), a leading manufacturer of innovative dialysis products, announced today the launch of the NxStage Freedom Tour, a two week road trip in a recreational vehicle to promote and educate dialysis patients on the benefits of home hemodialysis with the NxStage System One(TM). Traveling in the NxStage Freedom...

2014-07-10 04:21:24

STOCKHOLM, July 10, 2014 /PRNewswire/ -- Pharmalink AB, a specialty pharma company focused on orphan and niche products, has had core patents for its late-stage clinical candidate Nefecon(R) issued in the key markets United States, Europe, China and Hong Kong. A patent is pending in Japan. Nefecon is a potential disease-modifying treatment for patients with primary IgA nephropathy at risk of developing end-stage renal disease. Nefecon has shown positive results in an...

2014-07-08 23:15:45

Making it easier for patients to receive care close to home: Saint Luke's Kidney Transplant Satellite Clinic in Wichita will open in August 2014 to serve patients in the Wichita region who are in need of a kidney transplant. Kansas City, MO (PRWEB) July 08, 2014 For more than 30 years, patients in need of a kidney transplant in Wichita and surrounding areas have been able to receive high-quality, excellent care close to home. Now Saint Luke’s Hospital of Kansas City will maintain...

2014-06-30 12:32:19

Woman's Board of Northwestern Memorial Hospital gifts $500,000 to novel organ transplant trial CHICAGO, June 30, 2104 /PRNewswire/ -- A new Northwestern Medicine(®) clinical trial aims to remove the need for organ transplant patients to take immunosuppressive drugs by increasing the number of their own regulatory T cells (T-regs). The first-in-human, Phase I clinical trial, known as TRACT (T-regs for adoptive cell transfer), recently enrolled its first three participants in late May...

2014-06-30 08:29:40

- Result seen across stable and de novo kidney transplant patients - HORSHOLM, Denmark, June 30, 2014 /PRNewswire/ -- Veloxis Pharmaceuticals A/S (OMX: VELO) today announced that once-daily Envarsus(®) XR (tacrolimus extended-release tablets), an investigational new drug under FDA review for the prevention of organ rejection in adult kidney transplant patients, demonstrated a lower treatment failure rate in African-Americans compared with twice-daily tacrolimus (Prograf(®)). These study...


Latest Kidney transplantation Reference Libraries

2011-01-05 16:14:54

The BK virus, a member of the polyomavirus family, has no major consequences of infected except with those that are immunocomprimised or immunosuppressed. The virus was first isolated in 1971 from the urine sample of a renal transplant patient whose initials were B.K. Similar in genome sequences to the JCV virus they are most easily identified and differentiated from each other through serological tests using specific antibodies or through PCR based genotyping approach. Most people are...

More Articles (1 articles) »
Word of the Day
ween
  • To think; to imagine; to fancy.
  • To be of opinion; have the notion; think; imagine; suppose.
The word 'ween' comes from Middle English wene, from Old English wēn, wēna ("hope, weening, expectation"), from Proto-Germanic *wēniz, *wēnōn (“hope, expectation”), from Proto-Indo-European *wen- (“to strive, love, want, reach, win”).
Related